Latest "BioMedix Vascular Solutions" News Stories

19:34 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "BioMedix Vascular Solutions" found in our extensive news archives from over 250 global news sources.

More Information about BioMedix Vascular Solutions on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioMedix Vascular Solutions for you to read. Along with our medical data and news we also list BioMedix Vascular Solutions Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioMedix Vascular Solutions Companies for you to search.

Showing "BioMedix Vascular Solutions" News Articles 1–25 of 7,000+


Helix BioMedix Inc Strategic SWOT Analysis Review [Report Updated: 25072018] Prices from USD $125

Helix BioMedix Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business ...

Bluegrass Vascular completes enrollment of international SAVE registry with positive results

Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, has successfully completed enrollment

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

Increasing evidence suggests that cerebral vascular dysfunction is associated with the early stages of Alzheimer’s disease (AD). Vascular endothelial growth factor (VEGF) is one of the key players involved in ...

LeMaitre Vascular buys BD subsidiary for about $2.3M

LeMaitre Vascular has bought Becton Dickinson's France-based subsidiary Cardial, which makes knitted and woven vascular graft -More- 

Bluegrass Vascular Announces Positive Results From Independent Study Building On Growing Body ...

SAN ANTONIO, Oct. 27, 2018 /PRNewswire/ -- Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for Read more...

Humacyte starts US phase II vascular trauma trial of Humacyl

Humacyl is an investigational human acellular vessel (HAV), which is being evaluated for vascular replacement or reconstruction in patients with life- or limb-threatening vascular trauma. The study, which The post Humacyte starts US phase II vascular trauma trial of Humacyl appeared first on Compelo Medical Devices.

LeMaitre buys Applied Medical's vascular clot management biz

LeMaitre Vascular Inc. is paying $14.2mm--$11mm up front and $3.2mm in two later installments ($2mm in 12 months and $1.2m in...

FDA OKs Augmented Reality GLOW800 Vascular Fluorescence

Newly approved GLOW800 provides surgeons with a 'complete view of anatomy and physiology during vascular neurosurgery, the company says. FDA Approvals

LeMaitre buys Applied Medical's vascular clot business for $14M-plus

LeMaitre Vascular has acquired Applied Medical Resources' vascular clot business for $11 million in cash plus more than $3 mi -More- 

Chief operating officer named by Corindus Vascular

Corindus Vascular Robotics has promoted Douglas Teany from senior vice president of research and development and operations t -More- 

MRI markers of vascular brain injury associated with higher risk of stroke, dementia

Elderly patients with vascular brain injury (VBI) who carry MRI markers—including white matter hyperintensities of presumed vascular origin, MRI–defined covert brain infarcts, cerebral microbleeds and perivascular spaces—have an increased risk of stroke, dementia and death, according to new research published Oct. 22 in JAMA Neurology.

Intact Vascular to present TOBA II pivotal clinical trial data at VIVA Conference

Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that data from its Tack Optimized Balloon Angioplasty II pivotal clinical trial will be presented at the 15th Annual VIVA Conference in Las Vegas, NV on November 5-8.

Access Vascular gets $3.4M boost

A round of financing has brought in $3.4 million for Access Vascular.  -More- 

Study compares TCAR, transfemoral CAS in treating carotid stenosis

Data from a study presented at the Society for Vascular Surgery Vascular Annual Meeting showed transcarotid artery revascular -More- 

RUDN-based cardiologists studied new aspects of vascular ageing

(RUDN University) A team of scientists from the Medical Institute of RUDN University compared two factors of vascular ageing -- CF-PWV and CAVI. Both of these parameters determine the main indicator of vascular ageing -- arterial stiffness -- with high precision. However, they are influenced by age and certain metabolism abnormalities in different ways. The study is expected to help cardiologists ...

Corindus Vascular Promotes Douglas Teany to Chief Operating Officer

Douglas Teany has taken on a new role at Corindus Vascular Robotics (NYSE American: CVRS) as the Waltham, MA, company’s chief operating officer. Since 2016, he had served as Corindus’ senior vice president of R&D and operations. Corindus has commercialized the CorPath System, an FDA-cleared medical device that uses robotics technology in vascular procedures.

Funding round pulls in $12.4M for Vascular Therapies

A round of financing involving 29 investors has brought in $12.4 million for Cresskill, N.J.-based Vascular Therapies, bringi -More- 

Vascular Dynamics initiates study of hypertension device

A 300-patient pivotal trial has been launched by Vascular Dynamics to evaluate the use of its MobiusHD device in patients wit -More- 

Corindus Vascular closes $30M stock deal

Corindus Vascular Robotics has announced the completion of a deal with Cowen for an at-the-market offering of its common stoc -More- 

Japan clears Corindus Vascular's robotic surgical platform

Japan's Pharmaceuticals and Medical Devices Agency has granted Corindus Vascular Robotics clearance to market its CorPath GRX -More- 

Bluegrass Vascular expands patient enrollment in SAVE-US IDE study

In addition, Bluegrass Vascular has completed enrollment of its prospective, multicenter, post-CE Mark, international SAVE (Surfacer System to Facilitate Access in VEnous Occlusions) Registry. The company has claimed The post Bluegrass Vascular expands patient enrollment in SAVE-US IDE study appeared first on Compelo Medical Devices.

Augmented Reality Fluorescence Facilitates Vascular Neurosurgery

A surgical fluorescence solution uses indocyanine green (ICG) dye to display cerebral anatomy in natural colors, augmented by real-time vascular...

Teleflex acquires products from QT Vascular, gets option to another

Teleflex Inc. has acquired QT Vascular Ltd.’s non-drug coated products including the Chocolate XD and Glider percutaneous t...

Teleflex acquires vascular closure device maker Essential Medical

The Manta vascular closure device, which has received CE Mark, is specifically designed for closure of large bore arteriotomies after procedures utilizing devices or sheaths ranging in size The post Teleflex acquires vascular closure device maker Essential Medical appeared first on Compelo Medical Devices.

E-Cigarette Flavorings May Impair Vascular Function

THURSDAY, June 14, 2018 -- Flavoring additives used in electronic cigarettes (e-cigarettes) may have adverse effects on blood vessels, according to a study published online June 14 in Arteriosclerosis, Thrombosis, and Vascular Biology. Jessica L....

Quick Search


News Quicklinks